Inside Business Africa INSIDE BUSINESS AFRICA APRIL 2019 - Page 23

Investment I N S I D E B U S I N E S S A F R I C A Showcasing the continent US $1m Iconic Map of Africa Monument in South Africa unveiled T he US $1m Iconic Map of Africa Monument in South Africa has been unveiled after a year of construction at the Agulhas National Park in Southern Overberg region. Speaking during the launch ceremony Derek Hanekom, Tourism Minister, said the symbolism of the map pays homage to the mighty African continent. "South Africa's rich culture and heritage found in our national parks are key for tourism attraction. We can only therefore enhance these amazing tourism offerings by adding more features like the Iconic Map of Africa Monument to deliver memorable experiences to our visitors and ensure they return here again," said Derek Hanekom. Map of Africa Monument The million dollar project boasts a circumference of 30 metres. Located at the Southern most tip of Africa, it is one of the infrastructure features commissioned and developed at the Agulhas National Park by the D e p a r t m e n t o f To u r i s m i n collaboration with South African National Parks (SANParks), to enhance visitor experience and boost the local tourism economy. Works on the development included construction of the monument, a 1KM road, rehabilitation of the terrain and re-alignment of the boardwalk. The monument design shows the direction of the compass and includes representation of several African landmarks. It also lends itself to walking mediation or quiet contemplation while visitors behold the majestic confluence of the two mighty oceans - the Atlantic and Indian Oceans. During the project's implementation, 79 residents from the surrounding community were employed including 7 small, medium and micro enterprises (SMMEs). Additionally the constr uction provided training opportunities to different beneficiaries, the skills included plumbing, tiling, painting, plumbing, tiling and plastering. Phase two of this project, due to commence in April 2019, will be the development of Lighthouse Precinct Project, which will include construction of a conference facility, and 30 u t APRIL1 4 - 28, 2019 development a restaurant, interpretive centre, paving and walkways. Working for Tourism Programme Tourism is one of the main economic drivers and significant generator of jobs and revenue in South Africa. To give expression to its mandate, the Department of Tourism has been at the forefront of the commissioning and construction of destination enhancement tourism facilities through its Working for Tourism Programme. The Working for Tourism Programme supports both skills and infrastructure development projects. This is an Expanded Public Works Programme (EPWP) to promote employment opportunities and the transfer of skills to members of the community. By extension, it seeks to create jobs through Public Employment Programmes (PEP) for tourism, by increasing the labour intensity of government-funded infrastructure projects. INSIDE BUSINESS COMMEN- DATION AWARD THE MAGAZINE 0F THE CORPORATE WORLD A prescription for success The value of the African pharmaceutical market is growing rapidly, but the continent still imports over 70% of the drugs it consumes. David Thomas investigates what can be done to boost pharmaceutical manufacturing and R&D in Africa. O n the southern edge of the Sahel, the dusty, sun-parched frontier post of Makalondi regulates a centuries-old flow of goods between Niger and Burkina Faso. Buses and trucks piled high with household wares and agricultural produce travel back and forth, but little of consequence draws the attention of the wider world. However, in early 2018, this unassuming border post was the location of a raid linking Makalondi to an intricate West African crime network. Local police, coordinated by Interpol, intercepted and seized 29 tonnes of counterfeit medicines in two trucks thought to be travelling from Ghana. Three were arrested, and a wider investigation began. The Makalondi seizure was one of several raids organised across the continent between March and May 2018 by Interpol’s Illicit Goods and Global Heath unit to smash the smugglers and forgers responsible for a multi-billion dollar trade in fake and illicit drugs. In Dar es Salaam, Tanzania’s Food and Drug Administration seized $8,300- worth of counterfeit medical products, including antibiotics and antimalarial tablets, while in Zimbabwe, police seized 5,700 counterfeit tablets. Across West Africa, smuggling routes were uncovered linking inland markets to seaports in Benin, Ghana and Togo. In Mauritania, authorities seized tens of thousands of counterfeit medical products including antihistamines, corticosteroids, antibiotics, pregnancy tests and vitamin supplements. According to a 2018 report funded by the European Union, counterfeit medicines account for up to 30% of the global market. Counterfeiters prey on poor countries with porous borders, who suffer up to 30 times greater penetration of fakes in their supply chains compared to their wealthier peers. With Africa’s immense and changing disease burden and perpetual funding challenges, combined with an increasing need for pharmaceuticals and a reliance on foreign drugs, the continent is particularly vulnerable. Supply chain regulation, track-and-trace technology and enforcement regimes are lacking. As a result, the EU estimates that fakes may cause up to 158,000 deaths a year on the continent from malaria alone. Such criminal activity is piggybacking off a vast and increasing demand for genuine drugs across Africa, driven by economic growth, rising personal t 23 u APRIL1 4 - 28, 2019 African Pharma incomes, improving health systems and increased public spending. According to data from consulting firm McKinsey in 2015, the value of Africa’s pharmaceutical industry jumped from $4.7bn in 2003 to $20.8bn in 2013. By 2020 the market could be worth between $40bn and $60bn, the firm predicted, with over-the-counter, generic and prescription drug demand all expected to grow. Despite this vast appetite, it is estimated that the continent imports between 70 and 90% of the drugs it consumes, compared to 5% for China and around 20% for India. The continent only has around 375 drug makers, mostly in the North Africa region, South Africa, Nigeria and Kenya. By contrast, China and India are thought to have around 5,000 and 10,000 manufacturers respectively. Research and development for drugs is confined to a tiny handful of African universities, despite the fearful local toll of HIV AIDS, malaria and tuberculosis. Boosting manufacturing and R&D on the continent could be a source of immense untapped value and improve public health responses, according to Professor Bernd Rosenkranz, president of the Fundisa African Academy of Medicines Development. “Starting with research, the diseases are different and there are genetic differences in the response to treatment, so the drugs that may work well in New York may not work well in a local region of South Africa… “It’s good to have [manufacturing] in local countries for local health priorities. “There’s the financial and business side, the medical side, and political issues [supporting] manufacturing in Africa… I think there’s a good prospect for that but it has to be stepped up.” While there is a broad agreement that Africa could play a much greater role in the industry, experts acknowledge that there are huge gaps in the continent’s technical expertise, resource availability and regulatory architecture. With key organisations swinging behind the creation of domestic industries – including the United Nations, the African Union and regional economic communities – the continent is only